NAVIDEA BIOPHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dublin, OH
SEC filing record 1 source field available
Fiscal year end
31 December
NAVIDEA BIOPHARMACEUTICALS, INC. has filed 1,465 SEC EDGAR filings since 07 Feb 1995

SEC filing history

Showing 76-100 of 949 matching filings.

Per page
25
Current page
4
4/A

FORM 4/A

Filing date
30 Nov 2022
Reporting date
30 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
30 Nov 2022
Reporting date
30 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
30 Nov 2022
Reporting date
29 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
30 Nov 2022
Reporting date
30 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
30 Nov 2022
Reporting date
30 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
30 Nov 2022
Reporting date
30 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Nov 2022
Reporting date
31 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Nov 2022
Reporting date
31 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Nov 2022
Reporting date
31 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Nov 2022
Reporting date
31 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
25 Oct 2022
Reporting date
30 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-35076

FORM DEF 14A

Filing date
24 Oct 2022
Reporting date
08 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-35076

FORM PRE 14A

Filing date
13 Oct 2022
Reporting date
08 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-43603

SC 13G

Filing date
06 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Oct 2022
Reporting date
30 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Oct 2022
Reporting date
30 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Oct 2022
Reporting date
30 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Oct 2022
Reporting date
30 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-43603

SC 13D/A

Filing date
22 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-43603

SC 13D/A

Filing date
14 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Sep 2022
Reporting date
09 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .